Sarcoma News

Click here to read the Cover Story, “Despite potential, data on vitamin D’s benefits for cancer remain inconclusive.”

The FDA lifted a partial clinical hold it had placed on clinical trials designed to evaluate tazemetostat, according to the drug’s manufacturer.

A trial underway at Seattle Children’s Hospital will evaluate chimeric antigen receptor T-cell therapy for children and young adults with relapsed or refractory noncentral nervous system EGFR-expressing solid tumors.

A high-dose combination of busulfan and melphalan with autologous stem cell transplant improved survival compared with standard-of-care vincristine, dactinomycin and ifosfamide among patients with Ewing sarcoma, according to an international randomized trial.

Patients with advanced cancer experienced alleviated depressive symptoms and a reduction in end-of-life distress after taking part in a brief, tailored psychotherapeutic intervention called Managing Cancer and Living Meaningfully, or CALM, according to a randomized controlled trial published in Journal of Clinical Oncology.

Jeffrey Farma, MD, has been appointed chief of the division of general surgery within the department of surgery at Fox Chase Cancer Center.

Patients with cancer did not have significant reductions in treatment costs or health care use when treated by physicians at accountable care organizations compared to those treated by non-ACOs, according to a study of Medicare claims published in Journal of Clinical Oncology.

Anti-PD-1 immune checkpoint inhibitors demonstrated high efficacy with low toxicity in a small cohort of patients with HIV-positive Kaposi’s sarcoma, according to a study published in Cancer Immunology Research.

A Harvard Medical School project will mine multiple data sources to try to determine why some patients are more likely to have exceptional responses to cancer treatments.

The use of biosimilar biologics filgrastim-sndz and tbo-filgrastim increased substantially among Medicare beneficiaries between 2014 and 2016, according to a research letter published in JAMA.